Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Burkitt Lymphoma 35Leukemia, Myeloid, Acute 23Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 15Leukemia, Biphenotypic, Acute 13Leukemia, Myeloid, Accelerated Phase 11Lymphoma, Mantle-Cell 10Blast Crisis 10Myelodysplastic Syndromes 9Lymphoma, Non-Hodgkin 9Leukemia, Lymphocytic, Chronic, B-Cell 9Hodgkin Disease 9Congenital Abnormalities 9Myeloproliferative Disorders 8Lymphoma, Large B-Cell, Diffuse 8Leukemia, Myelomonocytic, Chronic 8Hematologic Neoplasms 7Primary Myelofibrosis 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Multiple Myeloma 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myeloid, Chronic-Phase 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large-Cell, Anaplastic 5Anemia, Refractory, with Excess of Blasts 5Sezary Syndrome 4Mycosis Fungoides 4Lymphoma 4

Interventions

carotuximab 2Methotrexate 2Leucovorin 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Dactinomycin 2Carboplatin 2Bevacizumab 2saracatinib 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1merphos 1etoposide phosphate 1cediranib 1Thiotepa 1Specimen Handling 1Second-Look Surgery 1Reoperation 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Paclitaxel 1Mesna 1Magnetic Resonance Spectroscopy 1Filgrastim 1Drug Therapy 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Choriocarcinoma × merphos × Clear all
NCT01535053 2022-08-12

Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia

GOG Foundation

Phase 3 Completed
57 enrolled 12 charts

Choriocarcinoma, Hydatidiform Mole

Data powered by HemOnc (CC BY 4.0) Colophon âš¡